Figure 5From: Adding pharmacogenomics to the development of new marine-derived anticancer agentsMolecular signatures of sensitivity to Aplidin (APLD) in acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) patient blasts.Back to article page